Prescription drug · NDA
Tembexa (Brincidofovir) NDC 64678-012
Brincidofovir 10 mg/mL · Suspension · Oral · Emergent BioDefense Operations Lansing LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64678-012-01 | 6467800120164678001201 | 65 mL in 1 BOTTLE (64678-012-01)Marketed from Apr 20, 2022 | |
| 64678-012-02 | 6467800120264678001202 | 65 mL in 1 BOTTLE (64678-012-02)Marketed from Apr 20, 2022 | |
| 64678-012-03 | 6467800120364678001203 | 1 BOTTLE in 1 CARTON (64678-012-03) / 45 mL in 1 BOTTLEMarketed from Jul 23, 2025 | |
| 64678-012-04 | 6467800120464678001204 | 1 BOTTLE in 1 CARTON (64678-012-04) / 45 mL in 1 BOTTLEMarketed from Jul 23, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tembexa
- Generic name (nonproprietary)
- brincidofovir
- Active ingredients
- Brincidofovir — 10 mg/mL
- Dosage form
- Suspension
- Route
- Oral
- Labeler
- Emergent BioDefense Operations Lansing LLCNDC labeler code 64678
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 214460
- Marketing start
- Listing expires
- Identifiers
- Product ID 64678-012_8ce2edcc-3c73-4a58-b96e-c7ba5408d3c9SPL ID 8ce2edcc-3c73-4a58-b96e-c7ba5408d3c9SPL set ID 0784838e-00bd-4b14-9b7e-653b7fbb7eeaRxCUI 2599525, 2599531UNII 6794O900AX
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N464678001201followed by a unit qualifier and the quantityPackage 64678-0012-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
TEMBEXA is an orthopoxvirus nucleotide analog DNA polymerase inhibitor and is indicated for the treatment of human smallpox disease in adult and pediatric patients, including neonates. ( 1.1 ) Limitations of Use: • TEMBEXA is not indicated for the treatment of diseases other than human smallpox disease. ( 1.2 ) • The effectiveness of TEMBEXA for treatment of smallpox disease has not been determined in humans because adequate and well-controlled field trials have not been feasible, and inducing smallpox disease in humans to study the drug’s efficacy is not ethical. ( 1.2 ) • TEMBEXA efficacy may be reduced in immunocompromised patients based on studies in immune deficient animals. ( 1.2 ) 1.1…
Excerpt only. Read the full label for complete information.
About NDC 64678-012
- What is NDC 64678-012?
- 64678-012 is the product NDC for Tembexa (brincidofovir), Brincidofovir 10 mg/mL suspension, listed with the FDA by Emergent BioDefense Operations Lansing LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tembexa (Brincidofovir).
- What is the active ingredient?
- Brincidofovir.
- Who is the labeler?
- Emergent BioDefense Operations Lansing LLC, NDC labeler code 64678. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tembexa?
- 1 other product NDC are listed under this name. See all Tembexa NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tembexa products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tembexabrincidofovir | Brincidofovir 100 mg/1 | Tablet, Film coatedOral | Emergent BioDefense Operations Lansing LLC | 64678-010 | 64678-0010-0164678-0010-02 |